Nonetheless, given the pragmatic application of DNA methylation profiles as non-invasive biomarkers [16], our observations on the prevalence of TBX2 subfamily hypermethylation in NSCLC suggest that methylation of these genes may serve as a high-potential biomarker for early detection and/or diagnosis of lung cancer. Here, TBX2 is linked to lung carcinoma.